Top 5 Stocks to Buy Now
→ Read this warning immediately (From Porter & Company) (Ad)tc pixel Free QTEX Stock Alerts

Inspira Technologies OXY B.H.N. (QTEX) Competitors

Inspira Technologies OXY B.H.N. logo
$2.01 0.00 (0.00%)
Closing price 06/18/2026 04:00 PM Eastern
Extended Trading
$2.08 +0.07 (+3.58%)
As of 06/18/2026 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

QTEX vs. CARL, SGHT, TMCI, TLSI, and PROF

Should you buy Inspira Technologies OXY B.H.N. stock or one of its competitors? MarketBeat compares Inspira Technologies OXY B.H.N. with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Inspira Technologies OXY B.H.N. include Carlsmed (CARL), Sight Sciences (SGHT), Treace Medical Concepts (TMCI), TriSalus Life Sciences (TLSI), and Profound Medical (PROF). These companies are all part of the "medical equipment" industry.

How does Inspira Technologies OXY B.H.N. compare to Carlsmed?

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) and Carlsmed (NASDAQ:CARL) are both small-cap manufacturing companies, but which is the better business? We will compare the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations.

12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Inspira Technologies OXY B.H.N. had 1 more articles in the media than Carlsmed. MarketBeat recorded 2 mentions for Inspira Technologies OXY B.H.N. and 1 mentions for Carlsmed. Inspira Technologies OXY B.H.N.'s average media sentiment score of 0.00 beat Carlsmed's score of -0.35 indicating that Inspira Technologies OXY B.H.N. is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspira Technologies OXY B.H.N.
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Carlsmed
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Carlsmed has a consensus target price of $19.33, suggesting a potential upside of 93.33%. Given Carlsmed's stronger consensus rating and higher probable upside, analysts clearly believe Carlsmed is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Carlsmed
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

Inspira Technologies OXY B.H.N. has higher earnings, but lower revenue than Carlsmed.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspira Technologies OXY B.H.N.$290K249.17-$13.22MN/AN/A
Carlsmed$50.51M5.38-$29.63M-$2.51N/A

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Carlsmed's net margin of -57.76%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Carlsmed's return on equity.

Company Net Margins Return on Equity Return on Assets
Inspira Technologies OXY B.H.N.N/A N/A N/A
Carlsmed -57.76%-60.74%-29.84%

Summary

Inspira Technologies OXY B.H.N. beats Carlsmed on 9 of the 13 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to Sight Sciences?

Sight Sciences (NASDAQ:SGHT) and Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) are both small-cap medical equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, earnings, valuation, media sentiment, profitability and analyst recommendations.

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Sight Sciences' net margin of -46.83%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Sight Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Sight Sciences-46.83% -52.34% -28.49%
Inspira Technologies OXY B.H.N. N/A N/A N/A

Sight Sciences presently has a consensus price target of $8.14, suggesting a potential upside of 54.24%. Given Sight Sciences' stronger consensus rating and higher possible upside, research analysts plainly believe Sight Sciences is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sight Sciences
1 Sell rating(s)
3 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.44
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Inspira Technologies OXY B.H.N. had 1 more articles in the media than Sight Sciences. MarketBeat recorded 2 mentions for Inspira Technologies OXY B.H.N. and 1 mentions for Sight Sciences. Sight Sciences' average media sentiment score of 0.59 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that Sight Sciences is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sight Sciences
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Inspira Technologies OXY B.H.N.
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Sight Sciences has a beta of 2.41, suggesting that its stock price is 141% more volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 4.11, suggesting that its stock price is 311% more volatile than the broader market.

55.5% of Sight Sciences shares are held by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. 30.9% of Sight Sciences shares are held by company insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Inspira Technologies OXY B.H.N. has lower revenue, but higher earnings than Sight Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sight Sciences$77.36M3.71-$38.43M-$0.71N/A
Inspira Technologies OXY B.H.N.$290K249.17-$13.22MN/AN/A

Summary

Sight Sciences and Inspira Technologies OXY B.H.N. tied by winning 7 of the 14 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to Treace Medical Concepts?

Treace Medical Concepts (NASDAQ:TMCI) and Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) are both small-cap medical equipment companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, risk, media sentiment, institutional ownership, earnings, profitability and analyst recommendations.

84.1% of Treace Medical Concepts shares are held by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. 23.4% of Treace Medical Concepts shares are held by insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Treace Medical Concepts currently has a consensus target price of $4.77, suggesting a potential upside of 13.84%. Given Treace Medical Concepts' stronger consensus rating and higher probable upside, analysts plainly believe Treace Medical Concepts is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Treace Medical Concepts
2 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.86
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Inspira Technologies OXY B.H.N. has lower revenue, but higher earnings than Treace Medical Concepts.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Treace Medical Concepts$212.69M1.28-$59M-$0.97N/A
Inspira Technologies OXY B.H.N.$290K249.17-$13.22MN/AN/A

Treace Medical Concepts has a beta of 1.4, suggesting that its stock price is 40% more volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 4.11, suggesting that its stock price is 311% more volatile than the broader market.

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Treace Medical Concepts' net margin of -29.44%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Treace Medical Concepts' return on equity.

Company Net Margins Return on Equity Return on Assets
Treace Medical Concepts-29.44% -67.04% -30.28%
Inspira Technologies OXY B.H.N. N/A N/A N/A

In the previous week, Inspira Technologies OXY B.H.N. had 1 more articles in the media than Treace Medical Concepts. MarketBeat recorded 2 mentions for Inspira Technologies OXY B.H.N. and 1 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 1.18 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that Treace Medical Concepts is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Treace Medical Concepts
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Inspira Technologies OXY B.H.N.
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Inspira Technologies OXY B.H.N. beats Treace Medical Concepts on 8 of the 14 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to TriSalus Life Sciences?

TriSalus Life Sciences (NASDAQ:TLSI) and Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) are both small-cap medical equipment companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, media sentiment, analyst recommendations and risk.

In the previous week, TriSalus Life Sciences had 1 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 3 mentions for TriSalus Life Sciences and 2 mentions for Inspira Technologies OXY B.H.N.. TriSalus Life Sciences' average media sentiment score of 0.00 equaled Inspira Technologies OXY B.H.N.'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TriSalus Life Sciences
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Inspira Technologies OXY B.H.N.
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

TriSalus Life Sciences presently has a consensus price target of $7.50, indicating a potential upside of 83.82%. Given TriSalus Life Sciences' stronger consensus rating and higher probable upside, equities analysts clearly believe TriSalus Life Sciences is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TriSalus Life Sciences
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Inspira Technologies OXY B.H.N. has lower revenue, but higher earnings than TriSalus Life Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TriSalus Life Sciences$45.15M5.55-$39.23M-$1.41N/A
Inspira Technologies OXY B.H.N.$290K249.17-$13.22MN/AN/A

TriSalus Life Sciences has a beta of 0.48, suggesting that its share price is 52% less volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 4.11, suggesting that its share price is 311% more volatile than the broader market.

2.6% of TriSalus Life Sciences shares are held by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. 16.3% of TriSalus Life Sciences shares are held by company insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to TriSalus Life Sciences' net margin of -60.85%.

Company Net Margins Return on Equity Return on Assets
TriSalus Life Sciences-60.85% N/A -69.91%
Inspira Technologies OXY B.H.N. N/A N/A N/A

Summary

Inspira Technologies OXY B.H.N. beats TriSalus Life Sciences on 7 of the 12 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to Profound Medical?

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) and Profound Medical (NASDAQ:PROF) are both small-cap medical equipment companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment, valuation and dividends.

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Profound Medical's net margin of -206.76%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Profound Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Inspira Technologies OXY B.H.N.N/A N/A N/A
Profound Medical -206.76%-78.88%-64.06%

In the previous week, Inspira Technologies OXY B.H.N. had 2 more articles in the media than Profound Medical. MarketBeat recorded 2 mentions for Inspira Technologies OXY B.H.N. and 0 mentions for Profound Medical. Inspira Technologies OXY B.H.N.'s average media sentiment score of 0.00 equaled Profound Medical'saverage media sentiment score.

Company Overall Sentiment
Inspira Technologies OXY B.H.N. Neutral
Profound Medical Neutral

Inspira Technologies OXY B.H.N. has higher earnings, but lower revenue than Profound Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspira Technologies OXY B.H.N.$290K249.17-$13.22MN/AN/A
Profound Medical$16.10M15.51-$42.57M-$1.24N/A

12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. Comparatively, 47.9% of Profound Medical shares are owned by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are owned by company insiders. Comparatively, 1.5% of Profound Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Inspira Technologies OXY B.H.N. has a beta of 4.11, indicating that its share price is 311% more volatile than the broader market. Comparatively, Profound Medical has a beta of 0.72, indicating that its share price is 28% less volatile than the broader market.

Profound Medical has a consensus target price of $12.00, indicating a potential upside of 74.67%. Given Profound Medical's stronger consensus rating and higher possible upside, analysts clearly believe Profound Medical is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Profound Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Inspira Technologies OXY B.H.N. beats Profound Medical on 8 of the 13 factors compared between the two stocks.

Get Inspira Technologies OXY B.H.N. News Delivered to You Automatically

Sign up to receive the latest news and ratings for QTEX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QTEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

QTEX vs. The Competition

Export
MetricInspira Technologies OXY B.H.N.Surgical, Medical, And Dental Instruments And Supplies IndustryManufacturing SectorNASDAQ Exchange
Market Cap$72.26M$2.73B$4.39B$12.59B
Dividend YieldN/AN/A10.41%5.68%
P/E RatioN/A13.3622.1224.44
Price / Sales249.17323.03161.08128.57
Price / CashN/A7.9940.7355.21
Price / Book33.506.1519.936.58
Net Income-$13.22M$7.39M$115.37M$337.17M
7 Day Performance55.81%1.37%0.80%0.61%
1 Month PerformanceN/A-4.21%2.52%5.02%
1 Year PerformanceN/A18.68%14.19%35.52%

Inspira Technologies OXY B.H.N. Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
QTEX
Inspira Technologies OXY B.H.N.
0.1766 of 5 stars		$2.01
flat		N/AN/A$72.26M$290KN/A20
CARL
Carlsmed
3.1717 of 5 stars		$9.98
-5.6%		$19.33
+93.7%		N/A$287.35M$50.51MN/A100
SGHT
Sight Sciences
2.68 of 5 stars		$5.01
-0.2%		$8.14
+62.5%		+23.7%$273.14M$79.55MN/A210
TMCI
Treace Medical Concepts
2.0851 of 5 stars		$4.01
-2.7%		$4.77
+19.0%		-23.3%$267.28M$207.32MN/A250
TLSI
TriSalus Life Sciences
3.1128 of 5 stars		$3.89
-6.5%		$7.50
+92.8%		-24.2%$255.49M$45.15MN/A106

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:QTEX) was last updated on 6/19/2026 by MarketBeat.com Staff.
From Our Partners
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel
A huge SpaceX error just led one stock to 3X move!
SPCE surged roughly 300% in a single week after investors hunting SpaceX exposure piled into the wrong ticker....
InvestPub | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel